Date | Insider | Price | Amount |
---|---|---|---|
11-7-2023 Insider Buy |
Scott Schlackman Director |
$68.89 CAGR » |
$3,626.78 53 shares |
11-7-2023 Insider Buy |
Michael A. Hoer Director |
$68.89 CAGR » |
$3,428.24 50 shares |
11-7-2023 Insider Buy |
Andrea B. Thomas Director |
$68.89 CAGR » |
$3,471.16 50 shares |
8-8-2023 Insider Buy |
Andrea B. Thomas Director |
$89.42 CAGR » |
$3,408.24 38 shares |
8-8-2023 Insider Buy |
Scott Schlackman Director |
$89.42 CAGR » |
$3,561.06 40 shares |
8-8-2023 Insider Buy |
Michael A. Hoer Director |
$89.42 CAGR » |
$3,366.13 38 shares |
5-9-2023 Insider Buy |
Scott Schlackman Director |
$87.50 CAGR » |
$1,150.19 13 shares |
5-9-2023 Insider Buy |
Andrea B. Thomas Director |
$87.50 CAGR » |
$1,133.04 13 shares |
5-9-2023 Insider Buy |
Constance J. Hallquist Director |
$87.50 CAGR » |
$1,167.42 13 shares |
5-9-2023 Insider Buy |
Michael A. Hoer Director |
$87.50 CAGR » |
$1,117.55 13 shares |
2-7-2023 Insider Buy |
Constance J. Hallquist Director |
$114.97 CAGR » |
$1,143.95 10 shares |
2-7-2023 Insider Buy |
Scott Schlackman Director |
$114.97 CAGR » |
$1,127.17 10 shares |
2-7-2023 Insider Buy |
Andrea B. Thomas Director |
$114.97 CAGR » |
$1,110.27 10 shares |
2-7-2023 Insider Buy |
Michael A. Hoer Director |
$114.97 CAGR » |
$1,095.09 10 shares |
8-9-2022 Insider Buy |
Jeffrey J. Brown Director |
$126.54 CAGR » |
$498,549.10 3,940 shares |
5-6-2020 Insider Buy |
Jeffrey J. Brown Director |
$95.12 CAGR » |
$94,889.01 998 shares |
11-9-2016 Insider Buy |
Jeffrey J. Brown Director |
$38.71 CAGR » |
$387,100.00 10,000 shares |
11-12-2018 Insider Buy |
Michael A. Hoer Director |
$156.23 CAGR » |
$31,246.00 200 shares |
3-14-2017 Insider Buy |
Glenn W. Welling Director |
$41.33 CAGR » |
$706,142.85 17,084 shares |
11-15-2016 Insider Buy |
Glenn W. Welling Director |
$39.02 CAGR » |
$1,365,567.94 35,000 shares |
8-6-2015 Insider Buy |
Glenn W. Welling Director |
$30.00 CAGR » |
$35,970.00 1,199 shares |
Also See: Institutional Holders of MED
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/08/2023 | |
End date: | 04/30/2024 | |
Start price/share: | $65.92 | |
End price/share: | $27.53 | |
Dividends collected/share: | $0.00 | |
Total return: | -58.24% | |
Annualized Gain: | -122.87% | |
Starting investment: | $10,000.00 | |
Ending investment: | $4,176.00 | |
Years: | 0.47 |
MED Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent MED insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MED
Free MED Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the MED Insider Buying occurred are:
BECN Insider Buying |